1. Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial. Issue 2 (2nd June 2022) Authors: Navarro-Compán, Victoria; Wei, James Cheng-Chung; Van den Bosch, Filip; Magrey, Marina; Wang, Lisy; Fleishaker, Dona; Cappelleri, Joseph C; Wang, Cunshan; Wu, Joseph; Dina, Oluwaseyi; Fallon, Lara; Strand, Vibeke Journal: RMD open Issue: Volume 8:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improved disease activity with fosdagrocorat (PF‐04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study. (22nd March 2017) Authors: Stock, Thomas; Fleishaker, Dona; Wang, Xin; Mukherjee, Arnab; Mebus, Charles Journal: International journal of rheumatic diseases Issue: Volume 20:Number 8(2017) Page Start: 960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. In Vitro and In Vivo Investigation of Potential for Complex CYP3A Interaction for PF‐00251802 (Dagrocorat), a Novel Dissociated Agonist of the Glucocorticoid Receptor. Issue 3 (7th November 2017) Authors: Ripp, Sharon L.; Mukherjee, Arnab; Eng, Heather; Stock, Thomas; Fleishaker, Dona; Checchio, Tina; Tammara, Brinda Journal: Clinical pharmacology in drug development Issue: Volume 7:Issue 3(2018) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study. (April 2021) Authors: Nash, Peter; Coates, Laura C; Fleishaker, Dona; Kivitz, Alan J; Mease, Philip J; Gladman, Dafna D; FitzGerald, Oliver; Wang, Cunshan; Wu, Joseph; Hsu, Ming-Ann; Menon, Sujatha; Fallon, Lara; Kanik, Keith S Journal: Lancet Issue: Volume 3:Number 4(2021) Page Start: e270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study. Issue 1 (December 2016) Authors: Fleishaker, Dona; Mukherjee, Arnab; Whaley, Fredrick; Daniel, Shanthini; Zeiher, Bernhardt Journal: BMC musculoskeletal disorders Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance. (January 2021) Authors: Nash, Peter; Mease, Philip J; Fleishaker, Dona; Wu, Joseph; Coates, Laura C; Behrens, Frank; Gladman, Dafna D; Kivitz, Alan J; Wei, James C; Shirinsky, Ivan; Menon, Sujatha; Romero, Ana B; Fallon, Lara; Hsu, Ming-Ann; Wang, Cunshan; Kanik, Keith S Journal: Lancet Issue: Volume 3:Number 1(2021) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Issue 8 (27th April 2021) Authors: Deodhar, Atul; Sliwinska-Stanczyk, Paula; Xu, Huji; Baraliakos, Xenofon; Gensler, Lianne S; Fleishaker, Dona; Wang, Lisy; Wu, Joseph; Menon, Sujatha; Wang, Cunshan; Dina, Oluwaseyi; Fallon, Lara; Kanik, Keith S; van der Heijde, Désirée Journal: Annals of the rheumatic diseases Issue: Volume 80:Issue 8(2021) Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study. Issue 8 (27th January 2017) Authors: van der Heijde, Désirée; Deodhar, Atul; Wei, James C; Drescher, Edit; Fleishaker, Dona; Hendrikx, Thijs; Li, David; Menon, Sujatha; Kanik, Keith S Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 8(2017) Page Start: 1340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients. (26th April 2018) Authors: Maksymowych, Walter P; Heijde, Désirée van der; Baraliakos, Xenofon; Deodhar, Atul; Sherlock, Sarah P; Li, David; Fleishaker, Dona; Hendrikx, Thijs; Kanik, Keith S Journal: Rheumatology Issue: Volume 57:Number 8(2018) Page Start: 1390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗